USANA Financial Statements From 2010 to 2024

USNA Stock  USD 40.53  0.20  0.50%   
USANA Health financial statements provide useful quarterly and yearly information to potential USANA Health Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on USANA Health financial statements helps investors assess USANA Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting USANA Health's valuation are summarized below:
Gross Profit
804.7 M
Profit Margin
0.063
Market Capitalization
772.5 M
Enterprise Value Revenue
0.5124
Revenue
862 M
We have found one hundred twenty available fundamental measures for USANA Health, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to double-check all of USANA Health latest market performance against the performance between 2010 and 2024 to make sure the company can sustain itself next year.

USANA Health Total Revenue

585.91 Million

Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 175.4 K, Total Revenue of 585.9 M or Gross Profit of 475.3 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0 or PTB Ratio of 2.58. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
  
Check out the analysis of USANA Health Correlation against competitors.

USANA Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding27.4 M19.3 M25.9 M
Slightly volatile
Total Assets664.4 M632.8 M455.9 M
Slightly volatile
Other Current Liabilities59.5 M86.8 M92.5 M
Slightly volatile
Total Current Liabilities76.4 M118.8 M113.5 M
Slightly volatile
Total Stockholder Equity522.1 M497.2 M324 M
Slightly volatile
Property Plant And Equipment Net60.7 M117.5 M81 M
Slightly volatile
Retained Earnings467.5 M445.2 M270.4 M
Slightly volatile
Accounts Payable8.2 M10.1 M9.9 M
Slightly volatile
Cash346.9 M330.4 M193.7 M
Slightly volatile
Non Current Assets Total110.9 M216.2 M163 M
Slightly volatile
Non Currrent Assets Other37.4 M35.6 M24.2 M
Slightly volatile
Cash And Short Term Investments346.9 M330.4 M198.5 M
Slightly volatile
Liabilities And Stockholders Equity664.4 M632.8 M455.9 M
Slightly volatile
Inventory40.7 M61.5 M58 M
Slightly volatile
Other Current Assets17.1 M17.5 M25.9 M
Very volatile
Other Stockholder Equity36.1 M65.7 M55.7 M
Slightly volatile
Total Liabilities88.4 M135.6 M128.3 M
Slightly volatile
Property Plant And Equipment Gross240.2 M228.8 M110.8 M
Slightly volatile
Total Current Assets437.4 M416.6 M285.1 M
Slightly volatile
Short and Long Term Debt Total10.3 M13.2 M8.3 M
Slightly volatile
Net ReceivablesM7.2 M9.5 M
Very volatile
Non Current Liabilities Total12.9 M16.7 M14.9 M
Slightly volatile
Short Term Debt11.9 M8.1 M12.6 M
Pretty Stable
Common Stock16.2 K17.1 K470.4 K
Slightly volatile
Property Plant Equipment68 M128.4 M84 M
Slightly volatile
Other Liabilities7.1 M12.1 M8.5 M
Slightly volatile
Good Will14.8 M17.1 M16.4 M
Pretty Stable
Intangible Assets28.3 M29.9 M32.9 M
Very volatile
Net Tangible Assets297.1 M442.4 M273 M
Slightly volatile
Capital Surpluse67 M57.5 M60.2 M
Pretty Stable
Non Current Liabilities Other7.9 M12.2 M6.4 M
Slightly volatile
Deferred Long Term Asset Charges2.9 MM6.5 M
Slightly volatile
Net Invested Capital451.8 M498 M391.3 M
Slightly volatile
Net Working Capital257.2 M298.9 M219.1 M
Slightly volatile
Capital Stock16.5 K17.1 K22 K
Slightly volatile
Capital Lease Obligations6.1 M7.3 M7.9 M
Slightly volatile
Short and Long Term Debt628.8 K707.4 K770.3 K
Slightly volatile

USANA Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue585.9 M921 M853 M
Slightly volatile
Gross Profit475.3 M731.6 M698.7 M
Slightly volatile
Operating Income81.3 M93.1 M119.4 M
Slightly volatile
EBIT80.5 M93.1 M118.8 M
Slightly volatile
EBITDA90.5 M113.5 M132.9 M
Slightly volatile
Net Income53.6 M63.8 M79 M
Slightly volatile
Depreciation And Amortization10.3 M20.4 M14.1 M
Slightly volatile
Other Operating Expenses522 M827.9 M736.1 M
Slightly volatile
Research Development12 M11.4 MM
Slightly volatile
Cost Of Revenue114.5 M189.4 M154.9 M
Slightly volatile
Total Operating Expenses407.5 M638.5 M581.2 M
Slightly volatile
Income Before Tax84.6 M102.5 M120.9 M
Slightly volatile
Selling General Administrative220.8 M257 M231.7 M
Slightly volatile
Net Income Applicable To Common Shares65.4 M79.8 M81 M
Slightly volatile
Net Income From Continuing Ops95.4 M59.8 M84.9 M
Slightly volatile
Selling And Marketing Expenses466.6 M394.3 M407.8 M
Slightly volatile
Tax Provision40.8 M38.8 M49.3 M
Pretty Stable
Interest Income8.6 M8.2 MM
Slightly volatile
Net Interest Income8.4 MM2.9 M
Slightly volatile
Reconciled Depreciation22.4 M20.8 M18.5 M
Slightly volatile

USANA Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow302.8 M288.4 M171.3 M
Slightly volatile
Depreciation10.3 M20.4 M14.1 M
Slightly volatile
Capital Expenditures12.3 M14.5 M14.3 M
Pretty Stable
Total Cash From Operating Activities73.2 M70.6 M103.4 M
Slightly volatile
Net Income55.4 M63.8 M79.3 M
Slightly volatile
End Period Cash Flow346.9 M330.4 M194.8 M
Slightly volatile
Other Cashflows From Investing Activities5.5 M5.2 M1.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.140.921.4193
Very volatile
PTB Ratio2.582.714.4009
Slightly volatile
Days Sales Outstanding2.92.372.6485
Very volatile
Book Value Per Share21.3220.3117.3389
Slightly volatile
Free Cash Flow Yield0.05490.08220.0716
Slightly volatile
Operating Cash Flow Per Share5.14.865.1843
Slightly volatile
Stock Based Compensation To Revenue0.01640.01540.0139
Pretty Stable
Capex To Depreciation0.530.560.7681
Slightly volatile
PB Ratio2.582.714.4009
Slightly volatile
EV To Sales1.50.861.291
Pretty Stable
Free Cash Flow Per Share4.594.374.582
Slightly volatile
ROIC0.170.180.2679
Slightly volatile
Inventory Turnover3.233.322.4692
Slightly volatile
Net Income Per Share3.43.244.5463
Pretty Stable
Days Of Inventory On Hand141145155
Slightly volatile
Payables Turnover10.1415.7915.1
Pretty Stable
Sales General And Administrative To Revenue0.360.30.3099
Slightly volatile
Research And Ddevelopement To Revenue0.01040.01330.0099
Slightly volatile
Capex To Revenue0.01140.0120.0146
Slightly volatile
Cash Per Share14.1613.4810.577
Slightly volatile
POCF Ratio9.788.8713.4219
Very volatile
Interest Coverage8995042.2 K
Slightly volatile
Capex To Operating Cash Flow0.110.120.133
Slightly volatile
PFCF Ratio10.359.8615.2232
Very volatile
Days Payables Outstanding40.4123.9227.126
Slightly volatile
Income Quality1.641.721.3011
Very volatile
ROE0.170.180.2813
Slightly volatile
EV To Operating Cash Flow12.688.2212.1544
Pretty Stable
PE Ratio12.9813.2915.5172
Pretty Stable
Return On Tangible Assets0.280.150.2141
Pretty Stable
EV To Free Cash Flow7.517.1513.2681
Pretty Stable
Earnings Yield0.08060.07790.0677
Pretty Stable
Intangibles To Total Assets0.080.07510.0949
Slightly volatile
Current Ratio1.442.412.1108
Slightly volatile
Tangible Book Value Per Share18.8817.9815.1419
Slightly volatile
Receivables Turnover149159151
Pretty Stable
Graham Number40.4138.4941.8022
Slightly volatile
Shareholders Equity Per Share21.3220.3117.3389
Slightly volatile
Capex Per Share0.330.490.5903
Very volatile
Revenue Per Share49.0146.6849.388
Slightly volatile
Enterprise Value Over EBITDA10.037.949.2191
Slightly volatile
Price Earnings Ratio12.9813.2915.5172
Pretty Stable
Operating Cycle146148158
Slightly volatile
Price Book Value Ratio2.582.714.4009
Slightly volatile
Days Of Payables Outstanding40.4123.9227.126
Slightly volatile
Price To Operating Cash Flows Ratio9.788.8713.4219
Very volatile
Price To Free Cash Flows Ratio10.359.8615.2232
Very volatile
Pretax Profit Margin0.10.09790.1297
Pretty Stable
Ebt Per Ebit0.790.910.9614
Very volatile
Operating Profit Margin0.10.0970.1316
Slightly volatile
Effective Tax Rate0.390.420.3357
Slightly volatile
Company Equity Multiplier1.931.581.5832
Pretty Stable
Long Term Debt To Capitalization0.0190.020.0467
Slightly volatile
Return On Capital Employed0.260.270.3973
Slightly volatile
Ebit Per Revenue0.10.0970.1316
Slightly volatile
Quick Ratio2.081.991.6146
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.038.998.2223
Pretty Stable
Net Income Per E B T0.520.570.6577
Slightly volatile
Cash Ratio1.891.81.4212
Slightly volatile
Cash Conversion Cycle76.0797.32127
Pretty Stable
Operating Cash Flow Sales Ratio0.0960.09360.1057
Slightly volatile
Days Of Inventory Outstanding141145155
Slightly volatile
Days Of Sales Outstanding2.92.372.6485
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.510.810.837
Pretty Stable
Price To Book Ratio2.582.714.4009
Slightly volatile
Fixed Asset Turnover7.379.1910.4813
Very volatile
Capital Expenditure Coverage Ratio5.038.998.2223
Pretty Stable
Price Cash Flow Ratio9.788.8713.4219
Very volatile
Enterprise Value Multiple10.037.949.2191
Slightly volatile
Price Sales Ratio1.140.921.4193
Very volatile
Return On Assets0.250.130.1928
Pretty Stable
Asset Turnover3.041.932.2107
Pretty Stable
Net Profit Margin0.06740.06250.0877
Pretty Stable
Gross Profit Margin0.640.730.8005
Slightly volatile
Price Fair Value2.582.714.4009
Slightly volatile
Return On Equity0.170.180.2813
Slightly volatile

USANA Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap98.7 M103.9 M1.2 B
Slightly volatile
Enterprise Value96.5 M101.6 MB
Slightly volatile

USANA Fundamental Market Drivers

Forward Price Earnings14.7275
Cash And Short Term Investments330.4 M

USANA Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About USANA Health Financial Statements

USANA Health stakeholders use historical fundamental indicators, such as USANA Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue13.9 M12 M
Total Revenue921 M585.9 M
Cost Of Revenue189.4 M114.5 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.36 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.01  0.01 
Revenue Per Share 46.68  49.01 
Ebit Per Revenue 0.10  0.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out the analysis of USANA Health Correlation against competitors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.85
Revenue Per Share
45.085
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0809
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.